Breast cancer is an incredibly heterogeneous disease, that includes multiple molecular and genomic subtypes with distinct clinical behavior and biological characteristics: luminal-A, luminal-B, HER2-positive, and basal-like. This evidence concerns the gene ERBB2 and breast carcinoma.